In this Issue:
Metformin in type 2 diabetes with kidney disease
HbA1c for predicting diabetes, and as an outcome
Predicting CSII efficacy in clinical practice
Long-term CSII efficacy in adults with type 1 diabetes
Pre- vs. postdinner resistance exercise and postprandial risk factors
Life expectancy in type 1 diabetes
Long-term intensive treatment and mortality in type 1 diabetes
Hospital-acquired conditions and length of stay in diabetics
Initial oral glucose-lowering medication choice
Modifiers of association between diabetes and first acute MI risk
Please login below to download this issue (PDF)